Prosecution Insights
Last updated: May 29, 2026
Application No. 18/124,091

SPINAL IMPLANT SYSTEM AND METHOD

Non-Final OA §102§103
Filed
Mar 21, 2023
Priority
Jan 24, 2020 — continuation of 11/612,419
Examiner
GREEN, MICHELLE CHRISTINE
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Warsaw Orthopedic, Inc.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
721 granted / 867 resolved
+13.2% vs TC avg
Moderate +12% lift
Without
With
+11.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
22 currently pending
Career history
896
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
76.2%
+36.2% vs TC avg
§102
14.6%
-25.4% vs TC avg
§112
5.6%
-34.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 867 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 21-24, 27-28, 30-36, 39-40 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Stanton et al. (U.S. Pub. No. 2018/0014890 A1, hereinafter “Stanton”). Stanton discloses, regarding claim 21, a method for treating a spine (see Figs. 2A-2G), the method comprising the steps of: connecting an end effector (201, see Fig. 2B, see also para. [0027]) to a first member (105, see Fig. 2B); connecting a second member (103) to the first member (see Fig. 2B, see para. [0015] “sliding engagement”); and positioning a third member (101) through the first member and the second member to adjust a depth of the third member relative to tissue and the end effector (see Fig. 2B, see para. [0015] “sliding engagement”, see para. [0016] “extends beyond”). Regarding claim 22, further comprising connecting the end effector with a robot arm (301, see Fig. 3, see para. [0027]). Regarding claim 23, wherein the robot arm includes position sensors (202, see Fig. 3, see para. [0027]) which measure and identify positional data points of the end effector in three-dimensional space for a guide-wireless insertion of the members with tissue (see Fig. 3, see para. [0027]). Regarding claim 24, wherein connecting the end effector to the first member comprises inserting the first member through a channel (e.g. channel of 203) of the end effector (see Fig. 2B, see para. [0028]). Regarding claim 27, wherein the end effector comprises opposite proximal (e.g. proximal end / top of 203) and distal end surfaces (e.g. distal end / bottom of 203), the distal end of the second member extending through the distal end surface (see Fig. 2B), the second member comprising an opposite proximal end that directly engages the proximal end surface (see Fig. 2B). Regarding claim 28, further comprising connecting a navigation component (119) with the third member (see Fig. 2B) such that the navigation component is positioned relative to a sensor to communicate a signal representative of an orientation of the third member (see para. [0032]). Regarding claim 30, wherein the third member extends through the end effector when the third member is positioned through the first member and the second member (see Fig. 2B, see para. [0016]). Regarding claim 31, wherein the third member extends through opposite proximal and distal end surfaces of the end effector when the third member is positioned through the first member and the second member (see Fig. 2B, see para. [0016]). Regarding claim 32, wherein the distal end of the second member extends through a distal end surface of the first member (see Fig. 2B, see para. [0016]). Regarding claim 33, wherein the distal end of the third member extends through the distal end of the second member (see Fig. 2B, see para. [0016]). Regarding claim 34, wherein the distal end of the third member includes a pointed tip (109, see Fig. 1A) configured to penetrate tissue (see Fig. 1A). Regarding claim 35, further comprising removing the third member from the first member and the second member (see Fig. 2F, see para. [0035]). Regarding claim 36, wherein the first member includes a cannulated dilator (see Fig. 2B, see para. [0015]). Stanton discloses, regarding claim 39, a method for treating a spine (see Figs. 2A-2G), the method comprising the steps of: connecting an end effector (201) to a dilator (105, see Fig. 2B); connecting a drill guide (103) to the dilator (see Fig. 2B, see para. [0015] “sliding engagement”); and positioning an anchor (101) through the dilator and the drill guide to adjust a depth of the anchor relative to tissue and the end effector (see Fig. 2B, see para. [0016] “extends beyond”). Stanton discloses, regarding claim 40, a method for treating a spine (see Figs. 2A-2G), the method comprising the steps of: connecting an end effector (201) to a first member (105, see Fig. 2B); connecting a second member (103) to the first member (see Fig. 2B, see para. [0015] “sliding engagement”); positioning a third member (101) through the first member and the second member to adjust a depth of the third member relative to tissue and the end effector (see Fig. 2B, see para. [0015] “sliding engagement” and see para. [0016] “extends beyond”); connecting a navigation component (119) with the third member (see Fig. 2B, see para. [0015] “sliding engagement”) such that the navigation component is positioned relative to a sensor to communicate a signal representative of an orientation of the third member (see para. [0032]); and connecting the end effector with a robot arm (301, see Fig. 3, see para. [0027]), wherein the robot arm includes position sensors (202, see Fig. 3, see para. [0027]) which measure and identify positional data points of the end effector in three-dimensional space for a guide-wireless insertion of the members with tissue (see Fig. 3, see para. [0027]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 25-26 is/are rejected under 35 U.S.C. 103 as being unpatentable over Stanton, as applied to claim 21 above, and in view of Kostrzewski et al. (U.S. Pub. No. 2015/0196365 A1, hereinafter “Kostrzewski”). Stanton discloses all of the features of the claimed invention, as previously set forth above, except regarding claim 25, wherein connecting the end effector to the first member comprises releasably engaging a lock of the end effector with the first member; and regarding claim 26, wherein the lock includes a spring button. Kostrzewski discloses a surgical instrument guide (1030) with a lock (1032) that includes a spring button (see para. [0094]) in order to lock the position of the instrument within the guide (see para. [0094]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the cannula of the end effector in Stanton to include a lock that includes a spring button in view of Kostrzewski in order to enable locking of the first member within the cannula of the end effector. Claim(s) 29 is/are rejected under 35 U.S.C. 103 as being unpatentable over Stanton, as applied to claim 21 above, and in view of Bush, JR. et al. (U.S. Pub. No. 2019/0269469 A1, hereinafter “Bush”). Stanton discloses all of the features of the claimed invention, as previously set forth above, except regarding claim 29, wherein the distal end of the second member comprises a plurality of teeth extending radially about the distal end of the second member. Bush discloses a second member (160, see Fig. 9), wherein the distal end (173) includes a plurality of teeth (178) extending radially about the distal end of the second member (see Fig. 9) in order to enable the distal end to penetrate into the bone so as to partially embed it within the bony anatomy (see para. [0089]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the distal end of the second member in Stanton to include a plurality of teeth extending radially about the distal end of the second member in view of Bush in order to enable the distal end to penetrate into the bone so as to partially embed it within the bony anatomy. Claim(s) 37-38 is/are rejected under 35 U.S.C. 103 as being unpatentable over Stanton, as applied to claim 21 above, and in view of Markworth (U.S. Pub. No. 2003/0233098 A1, hereinafter “Markworth”). Stanton discloses all of the features of the claimed invention, as previously set forth above, except regarding claim 37, wherein the second member includes a part configured to adjust the depth of the third member relative to tissue and the end effector; and regarding claim 38, wherein the part is translatable to adjust the depth of the third member. Markworth discloses a second member (14) with a part (16) translatable to adjust the depth of a third member (12) in order to control the desired depth of the insertion of the third member and prevent over insertion or under insertion of the third member (see paras. [0047] and [0059]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the second member in Stanton to include a part translatable to adjust the depth of the third member relative to the tissue in view of Markworth in order to control the desired depth of the insertion of the third member and prevent over insertion or under insertion of the third member. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See PTO-892. The following references disclose depth adjusters for surgical instruments: PNG media_image1.png 222 616 media_image1.png Greyscale Any inquiry concerning this communication or earlier communications from the examiner should be directed to Michelle C. Green whose telephone number is (571)270-7051. The examiner can normally be reached on Monday-Friday between 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Eduardo C. Robert, at (571) 272-4719. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /M.C.G/ Examiner, Art Unit 3773 /EDUARDO C ROBERT/ Supervisory Patent Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

Mar 21, 2023
Application Filed
Apr 23, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12611236
IMPLANT WITH INTRAMEDULLARY PORTION AND OFFSET EXTRAMEDULLARY PORTION
2y 6m to grant Granted Apr 28, 2026
Patent 12594099
ROD REDUCTION INSTRUMENT FEEDBACK SYSTEM
3y 1m to grant Granted Apr 07, 2026
Patent 12589006
Expandable Vertebral Implant and Method
3y 5m to grant Granted Mar 31, 2026
Patent 12588935
INTERSPINOUS IMPLANT INSERTION INSTRUMENT WITH STAGGERED PATH IMPLANT DEPLOYMENT MECHANISM
3y 6m to grant Granted Mar 31, 2026
Patent 12588936
LAG SCREW SYSTEMS AND NAIL SYSTEMS AND METHODS INCORPORATING THE SAME
3y 4m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
95%
With Interview (+11.8%)
2y 7m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 867 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month